| Recent progress in drug delivery C Li, J Wang, Y Wang, H Gao, G Wei, Y Huang, H Yu, Y Gan, Y Wang, ... Acta pharmaceutica sinica B 9 (6), 1145-1162, 2019 | 780 | 2019 |
| A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals Y Wang, K Zhou, G Huang, C Hensley, X Huang, X Ma, T Zhao, BD Sumer, ... Nature Materials 13 (2), 204-212, 2014 | 762 | 2014 |
| Tunable, ultrasensitive pH‐responsive nanoparticles targeting specific endocytic organelles in living cells K Zhou, Y Wang, X Huang, K Luby‐Phelps, BD Sumer, J Gao Angewandte Chemie International Edition 50 (27), 6109-6114, 2011 | 567 | 2011 |
| Multicolored pH-tunable and activatable fluorescence nanoplatform responsive to physiologic pH stimuli K Zhou, H Liu, S Zhang, X Huang, Y Wang, G Huang, BD Sumer, J Gao Journal of the American Chemical Society 134 (18), 7803-7811, 2012 | 351 | 2012 |
| Current multistage drug delivery systems based on the tumor microenvironment B Chen, W Dai, B He, H Zhang, X Wang, Y Wang, Q Zhang Theranostics 7 (3), 538, 2017 | 320 | 2017 |
| Ultra-pH-sensitive nanoprobe library with broad pH tunability and fluorescence emissions X Ma, Y Wang, T Zhao, Y Li, LC Su, Z Wang, G Huang, BD Sumer, J Gao Journal of the American Chemical Society 136 (31), 11085-11092, 2014 | 272 | 2014 |
| Overcoming endosomal barrier by amphotericin B-loaded dual pH-responsive PDMA-b-PDPA micelleplexes for siRNA delivery H Yu, Y Zou, Y Wang, X Huang, G Huang, BD Sumer, DA Boothman, ... ACS Nano 5 (11), 9246-9255, 2011 | 245 | 2011 |
| A transistor-like pH nanoprobe for tumour detection and image-guided surgery T Zhao, G Huang, Y Li, S Yang, S Ramezani, Z Lin, Y Wang, X Ma, Z Zeng, ... Nature Biomedical Engineering 1 (1), 1-8, 2016 | 203 | 2016 |
| A pyroptosis nanotuner for cancer therapy B Chen, Y Yan, Y Yang, G Cao, X Wang, Y Wang, F Wan, Q Yin, Z Wang, ... Nature Nanotechnology 17 (7), 788-798, 2022 | 181 | 2022 |
| An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis X Huang, Y Dong, EA Bey, JA Kilgore, JS Bair, LS Li, M Patel, ... Cancer Research 72 (12), 3038-3047, 2012 | 167 | 2012 |
| Cooperativity principles in self-assembled nanomedicine Y Li, Y Wang, G Huang, J Gao Chemical Reviews 118 (11), 5359-5391, 2018 | 158 | 2018 |
| Redox-activated porphyrin-based liposome remote-loaded with indoleamine 2, 3-dioxygenase (IDO) inhibitor for synergistic photoimmunotherapy through induction of immunogenic … D Liu, B Chen, Y Mo, Z Wang, T Qi, Q Zhang, Y Wang Nano Letters 19 (10), 6964-6976, 2019 | 153 | 2019 |
| Multi‐chromatic pH‐activatable 19F‐MRI nanoprobes with binary ON/OFF pH transitions and chemical‐shift barcodes X Huang, G Huang, S Zhang, K Sagiyama, O Togao, X Ma, Y Wang, Y Li, ... Angewandte Chemie International Edition 125 (31), 8232-8236, 2013 | 133 | 2013 |
| Single-walled carbon-nanohorns improve biocompatibility over nanotubes by triggering less protein-initiated pyroptosis and apoptosis in macrophages B He, Y Shi, Y Liang, A Yang, Z Fan, L Yuan, X Zou, X Chang, H Zhang, ... Nature Communications 9 (1), 1-21, 2018 | 130 | 2018 |
| Smart drug delivery systems for precise cancer therapy X Wang, C Li, Y Wang, H Chen, X Zhang, C Luo, W Zhou, L Li, L Teng, ... Acta Pharmaceutica Sinica B 12 (11), 4098-4121, 2022 | 118 | 2022 |
| A pH-activatable nanoparticle for dual-stage precisely mitochondria-targeted photodynamic anticancer therapy T Qi, B Chen, Z Wang, H Du, D Liu, Q Yin, B Liu, Q Zhang, Y Wang Biomaterials 213, 119219, 2019 | 109 | 2019 |
| Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy X Ma, X Huang, Z Moore, G Huang, JA Kilgore, Y Wang, S Hammer, ... Journal of Controlled Release 200, 201-211, 2015 | 108 | 2015 |
| Delivery of drugs to cell membranes by encapsulation in PEG–PE micelles J Wang, Y Wang, W Liang Journal of Controlled Release 160 (3), 637-651, 2012 | 95 | 2012 |
| NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells X Wang, Y Wang, X Chen, J Wang, X Zhang, Q Zhang Journal of Controlled Release 139 (1), 56-62, 2009 | 95 | 2009 |
| Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature T Yang, Y Wang, Z Li, W Dai, J Yin, L Liang, X Ying, S Zhou, J Wang, ... Nanomedicine: Nanotechnology, Biology and Medicine 8 (1), 81-92, 2012 | 88 | 2012 |
Jinming GaoUT Southwestern Medical CenterEmail confirmado em utsouthwestern.edu
